BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 1309726)

  • 1. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
    Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J
    Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Invasive, metastatic growth of lymphoblastoid B cells in immunodeficient SCID mice].
    Walter J; Wolf J; Pawlita M; Schirrmacher V; Moldenhauer G; Möller P
    Verh Dtsch Ges Pathol; 1991; 75():224-8. PubMed ID: 1724838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells.
    Wolf J; Draube A; Bohlen H; Jox A; Mücke S; Pawlita M; Möller P; Diehl V
    Int J Cancer; 1995 Feb; 60(4):527-33. PubMed ID: 7829268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regressing nude mouse grafts of Burkitt's lymphoma x lymphoblastoid cell hybrids show deregulation of the c-myc gene and expression of the EBV latent membrane protein.
    Wolf J; Klevenz B; Pawlita M; Komitowski D; Moldenhauer G; zur Hausen H
    Int J Cancer; 1991 Jan; 47(1):99-104. PubMed ID: 1702406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination.
    Walter J; Schirrmacher V; Mosier D
    Int J Cancer; 1995 May; 61(3):363-9. PubMed ID: 7537255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
    Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of new human Burkitt's lymphoma cell lines (HBL-7 and HBL-8) that are highly metastatic in SCID mice: a metastatic SCID mouse model of human lymphoma lines.
    Abe M; Suzuki O; Tasaki K; Abe R; Wakasa H
    Pathol Int; 1996 Sep; 46(9):630-8. PubMed ID: 8905871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
    Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H
    Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkitt's lymphoma cell lines reveal different degrees of tumorigenicity in nude mice.
    Gurtsevitch VE; O'Conor GT; Lenoir GM
    Int J Cancer; 1988 Jan; 41(1):87-95. PubMed ID: 2826348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
    Billaud M; Rousset F; Calender A; Cordier M; Aubry JP; Laisse V; Lenoir GM
    Blood; 1990 May; 75(9):1827-33. PubMed ID: 1691936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
    Wolf J; Jox A; Skarbek H; Pukrop T; Bartnitzke S; Pawlita M; Diehl V; Bullerdiek J
    Virology; 1995 Sep; 212(1):179-85. PubMed ID: 7676627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
    Gregory CD; Murray RJ; Edwards CF; Rickinson AB
    J Exp Med; 1988 Jun; 167(6):1811-24. PubMed ID: 2898508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human B-lymphoid cell lines.
    Nilsson K
    Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
    Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
    Rowe M; Young LS; Crocker J; Stokes H; Henderson S; Rickinson AB
    J Exp Med; 1991 Jan; 173(1):147-58. PubMed ID: 1845872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diploid human lymphoblastoid and Burkitt lymphoma cell lines: susceptibility to murine NK cells and heterotransplantation to nude mice.
    McCormick KH; Giovanella BC; Klein G; Nilsson K; Stehlin JS
    Int J Cancer; 1981 Oct; 28(4):455-8. PubMed ID: 6273332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.